Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02893543
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G65 | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6A | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G68 | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG7 | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6C | 0.7 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG6 | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 1OEX | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWX | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVW | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVX | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWW | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 1GKT | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWC | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVV | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVT | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2VS2 | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 1OEW | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVU | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2JJJ | 0.7 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2JJI | 0.7 | |
NSK | N-SUCCINYL LYSINE | A | 2P8B | 0.7 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.75 | |
EP2 | methyl N-[(2S)-4-{[(1S)-1-{[(2S)- 2-carboxypyrrolidin-1-yl]carbonyl}- 3-methylbutyl]amino}-2-hydroxy- 4-oxobutanoyl]-L-leucylglycylglycinate | B | 1SP4 | 0.73 | |
2Z9 | N-acetyl-L-alpha-aspartyl-L-alpha- glutamyl-N-[(1R)-2-carboxy-1-formylethyl]- L-valinamide | A,B | 3H1P | 0.72 | |
LAE | 3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO- FURAN-3-YL)-AMIDE | A,B,C,D | 1L3L | 0.7 | |
LAE | 3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO- FURAN-3-YL)-AMIDE | A,B | 2Q0O | 0.7 | |
SUJ | (2R,3R)-2-[(3S,6R)-3-AMINO-6-HYDROXY- 2-OXOPIPERIDINYL]-3-HYDROXYBUTANOIC ACID | C,D | 1OKX | 0.7 | |
SUO | N~2~-(3-CARBOXYPROPANOYL)-L-ORNITHINE | A,B,C,D | 1YNH | 0.75 | |
74M | METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN- 2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE | A | 2DC9 | 0.78 |